<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01212640</url>
  </required_header>
  <id_info>
    <org_study_id>TRALI STUDY. SEMICYUC</org_study_id>
    <nct_id>NCT01212640</nct_id>
  </id_info>
  <brief_title>GROUP FOR TRALI STUDY. SEMICYUC.</brief_title>
  <official_title>GROUP FOR TRALI STUDY. SEMICYUC.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospitales Universitarios Virgen del Rocío</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Reina Sofia de Cordoba</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. Negrin University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitari Son Dureta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Miguel Servet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      OBJETIVES:

        1. To research the worsening of respiratory status risk factors after transfusion in
           spanish critical care units.

        2. To determine the incidence of transfusion-related acute lung injury (TRALI) in
           critically ill patients.

        3. To research the morbi-mortality of TRALI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Actually there are no published European data on the incidence of acute lung injury by
      transfusion (TRALI) in critically ill patients, in Europe, estimates of TRALI incidence are
      limited to passive reports of national blood banks. This multicenter study of Spanish ICUs
      will investigate the incidence and TRALI predisposing factors (associated with the patient,
      the transfused blood product and the presence or absence of mechanical ventilation).

      Design:

      Prospective multicenter observational study.

      Patients:

      All patients transfused in eleven spanish intensive care units (UCI) from October 1, until
      November 30, 2010. Patients with less of 18 years old, or transfused six hours before be
      included in this study or seriousness patients with a length of stay &lt;24 hrs will be
      excluded.

      Variables:

        -  Patient data collection: Demografic data (age, gender), Clinical data (comorbid
           conditions), Admission diagnostic , Complications during the stay and severity of
           illness scores: Acute Physiology and Chronic Health Evaluation (APACHE II) score,
           Sequential Organ Failure Assessment (SOFA) score, Euroscore.

        -  Transfusion factors: Type of blood product, time of infusion and volumen transfused,
           storage age and donor sex.

        -  Respiratory factors: Main ventilation and oxigenation parameters and type of respiratory
           support before and after transfusion.

      For each transfusion episode was completed two data tables (see last page of the booklet of
      data collection):

        -  Before the transfusion (baseline) are listed the values of the patient's respiratory
           function, the analytical value that is transfused (Hb, INR, APTT, PT, platelets) and the
           number of the bag that is transfused (to apply blood bank storage time and sex of the
           donor).

        -  After the transfusion are recorded the volume and time infusion and 6 hours after
           transfusion are collected again the parameters of the patient's respiratory function and
           radiographic changes.

      According to official criteria shall be noted if the patient has exhibited a classic TRALI,
      possible TRALI, or a worsening of their respiratory function after transfusion.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Worsening of respiratory status</measure>
    <time_frame>October-November</time_frame>
    <description>To research the worsening of respiratory status risk factors after transfusion in spanish critical care units.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence and morbi-mortality of TRALI</measure>
    <time_frame>October-November</time_frame>
    <description>Determine the incidence and morbi-mortality of transfusion-related acute lung injury (TRALI) in critically ill patients.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Acute Lung Injury</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients transfused in eleven spanish intensive care units (UCI) from October 1, until
        November 30, 2010. Patients with less of 18 years old, or transfused six hours before be
        included in this study or seriousness patients with a length of stay &lt;24 hrs will be
        excluded.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients transfused in eleven spanish intensive care units (UCI) from October 1,
             until November 30, 2010.

        Exclusion Criteria:

          -  Patients with less of 18 years old, or transfused six hours before be included in this
             study or seriousness patients with a length of stay &lt;24 hrs will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CARMEN MARIA FERRANDIZ, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>CARMEN MARIA FERRANDIZ, MD</last_name>
    <phone>955012528</phone>
    <email>carmenmferrandizm@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Virgen Del Rocio</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>CARMEN MARIA FERRANDIZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen Del Rocio</name>
      <address>
        <city>Seville</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>CARMEN MARIA FERRANDIZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Silliman CC, Fung YL, Ball JB, Khan SY. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 2009 Nov;23(6):245-55. doi: 10.1016/j.blre.2009.07.005. Epub 2009 Aug 20. Review.</citation>
    <PMID>19699017</PMID>
  </reference>
  <reference>
    <citation>Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D; National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005 Apr;33(4):721-6. Review.</citation>
    <PMID>15818095</PMID>
  </reference>
  <reference>
    <citation>Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA; TRALI Consensus Panel. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev. 2005 Jan;19(1):2-31.</citation>
    <PMID>15830325</PMID>
  </reference>
  <reference>
    <citation>Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med. 2007 Nov 1;176(9):886-91. Epub 2007 Jul 12.</citation>
    <PMID>17626910</PMID>
  </reference>
  <reference>
    <citation>Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005 Jun;33(6):1191-8.</citation>
    <PMID>15942330</PMID>
  </reference>
  <reference>
    <citation>Eder AF, Benjamin RJ. TRALI risk reduction: donor and component management strategies. J Clin Apher. 2009;24(3):122-9. doi: 10.1002/jca.20198. Review.</citation>
    <PMID>19365816</PMID>
  </reference>
  <reference>
    <citation>Yilmaz M, Keegan MT, Iscimen R, Afessa B, Buck CF, Hubmayr RD, Gajic O. Toward the prevention of acute lung injury: protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med. 2007 Jul;35(7):1660-6; quiz 1667.</citation>
    <PMID>17507824</PMID>
  </reference>
  <reference>
    <citation>Benson AB, Moss M, Silliman CC. Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol. 2009 Nov;147(4):431-43. doi: 10.1111/j.1365-2141.2009.07840.x. Epub 2009 Aug 5. Review.</citation>
    <PMID>19663827</PMID>
  </reference>
  <reference>
    <citation>Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, Shorr AF. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care. 2007;11(3):R63.</citation>
    <PMID>17553147</PMID>
  </reference>
  <reference>
    <citation>Chaiwat O, Lang JD, Vavilala MS, Wang J, MacKenzie EJ, Jurkovich GJ, Rivara FP. Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma. Anesthesiology. 2009 Feb;110(2):351-60. doi: 10.1097/ALN.0b013e3181948a97.</citation>
    <PMID>19164959</PMID>
  </reference>
  <reference>
    <citation>Silverboard H, Aisiku I, Martin GS, Adams M, Rozycki G, Moss M. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma. 2005 Sep;59(3):717-23.</citation>
    <PMID>16361918</PMID>
  </reference>
  <reference>
    <citation>Vlaar AP, Binnekade JM, Prins D, van Stein D, Hofstra JJ, Schultz MJ, Juffermans NP. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med. 2010 Mar;38(3):771-8. doi: 10.1097/CCM.0b013e3181cc4d4b.</citation>
    <PMID>20035217</PMID>
  </reference>
  <reference>
    <citation>Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ. 1999 Jul 3;319(7201):16-9.</citation>
    <PMID>10390452</PMID>
  </reference>
  <reference>
    <citation>Wiersum-Osselton JC, Porcelijn L, van Stein D, Vlaar AP, Beckers EA, Schipperus MR. [Transfusion-related acute lung injury (TRALI) in the Netherlands in 2002-2005]. Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1784-8. Dutch.</citation>
    <PMID>18754313</PMID>
  </reference>
  <reference>
    <citation>Rebibo D, Hauser L, Slimani A, Hervé P, Andreu G. The French Haemovigilance System: organization and results for 2003. Transfus Apher Sci. 2004 Oct;31(2):145-53.</citation>
    <PMID>15501418</PMID>
  </reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2010</study_first_submitted>
  <study_first_submitted_qc>September 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2010</study_first_posted>
  <last_update_submitted>September 29, 2010</last_update_submitted>
  <last_update_submitted_qc>September 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>CARMEN MARIA FERRANDIZ MILLON</name_title>
    <organization>FISEVI</organization>
  </responsible_party>
  <keyword>Transfusion, distress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

